Glaukos Corporation (GKOS) Tops Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Glaukos Corporation (GKOS) Tops Q4 EPS by 5c

Glaukos Corporation Announces Fourth Quarter and Full Year 2020 Financial Results

February 25, 2021 4:10 PM EST

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the fourth quarter and full year ended December 31, 2020. Key highlights include:

Net sales of $73.2 million in Q4 2020, compared to $65.8 million in Q4 2019. Glaucoma net sales of $58.4 million and Corneal Health net sales of $14.9 million in Q4 2020. Gross margin of approximately 73% and non-GAAP gross margin of approximately 83% in Q4 2020. Operating expenses... More